Fibromuscular dysplasia (FMD) mainly affects renal arteries. Percutaneous transluminal renal angioplasty (PTRA) and surgery are effective treatments, but longtime follow-up is lacking. Retrospective follow-up for 7.074.7 years of 69 consecutive patients (age 44713 years) treated for hypertension due to FMD, 59 patients underwent PTRA and eight patients surgery. In two patients no PTRA was performed. Technical success was achieved in 56 (95%) patients undergoing PTRA and all eight undergoing surgery. After successful PTRA, both systolic and diastolic blood pressures (SBP and DBP) had decreased at discharge (from 174733/ 100713 to 138719/80715 mmHg; Po0.0001), and remained lower at 1 month, 1 year, and last follow-up after 7.074.7 years (140725/83712 mmHg; Po0.0001). Serum-creatinine had decreased both at 1 year (from 84728 to 75713 lmol/l; P ¼ 0.0030) and last follow-up (75716 lmol/l; P ¼ 0.0017). The number of antihypertensive drugs decreased (from 2.371.2 before PTRA to 1.471.3 at discharge and at 1 month; Po0.0001, and 1.671.5 at last follow-up; P ¼ 0.0011). SBP decreased more after PTRA among patients with FMD only in the main renal artery than in those with branch artery involvement (43729 vs 20741 mmHg; P ¼ 0.0198). Beneficial effects on BP, creatinine and antihypertensive drugs also occurred after surgery. Patients on antihypertensive drugs at last follow-up had longer hypertension duration before PTRA than those without (5.977.7 vs 1.874.1 years; P ¼ 0.0349). Cure was achieved in 16 (24%), improvement in another 26(39%), and benefit in 42(63%). In conclusion, renal artery FMD, PTRA and surgery have beneficial long-term effects, negatively affected by hypertension duration and branch artery involvement.